SK

Saket Kumar

Active Director Director DIN 07875710
DIN 07875710 First appointment Jul 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2017
Shareholding value •••• Premium profile

About Saket Kumar

Data last updated:

Saket Kumar is a Director at Younker Pharmaceutical Private Limited (since 2017). The company operates in Pharma. Younker Pharmaceutical Private Limited reported revenue of ₹47.7 Lakh (FY 2023).

DIN 07875710
Primary Designation Director
Industry Pharma
First Appointment 21 Jul 2017
Oldest Company Age 9 yrs
Largest company Younker Pharmaceutical Private Limited · ₹47.7 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jul 20172017₹47.7 Lakh (FY 2023)Active

Board colleagues of Saket Kumar

Directorship timeline

Open interactive timeline →
Younker Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Saket Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saket Kumar

Saket Kumar currently holds 1 directorship: Younker Pharmaceutical Private Limited (Director, since 21 Jul 2017, revenue ₹47.7 Lakh (FY 2023)).

Saket Kumar was first appointed on 21 Jul 2017 as Director at Younker Pharmaceutical Private Limited.

The current boards of Saket Kumar's companies include Amit Kumar (Younker Pharmaceutical Private Limited), Amit Ranjan (Younker Pharmaceutical Private Limited), Virochan Kumar (Younker Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available